Published Date: 17 Feb 2023
A new study found that oral gefitinib plus parenteral methotrexate was no more clinically effective than methotrexate alone. Search results...
Read Full NewsA recent study conducted at the University of Turku in Finland showed that hyperemesis gravidarum, a severe form of nausea that occurs during pregnancy, is linked to depression. Women who experienced severe nausea were more ...
For cases of mild congenital heart defects (CHDs), more prenatal visits are associated with lower probability of delivery at a cardiac center, according to a study published online Nov. 9 in JAMA Network Open to coincide ...
Researchers at the University of Illinois Urbana-Champaign report that extracellular vesicles released into the bloodstream during aerobic exercise can, on their own, drive a robust increase in adult hippocampal neurogenesis ...
The record-breaking federal government shutdown marked yet another impediment to scientific research efforts at the Wistar Institute this year.
A new software enables brain simulations which both imitate the processes in the brain in detail and can solve challenging cognitive tasks. The program was developed by a research team at the Cluster of Excellence "Machine ...
Bracken Babula starts patient visits these days by closing the exam room door and asking if they mind him recording their conversation. He hits a button on his mobile phone, checks that it is recording, and sits back in his ...
As the holiday season approaches, Pennington Biomedical Research Center is sharing tips and advice to help families enjoy their celebrations while feeling their best. Building on the Center's popular "Small Shifts" campaign, ...
1.
Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer
2.
AI model combines clinical and magnetic resonance data to improve prediction of breast cancer recurrence
3.
Cancerous breast tissue glows in new AI-enhanced MRI images
4.
Prostate cancer death risk is higher in late teens and early 20s weight gain.
5.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
1.
A Clinical Review of Novel Therapeutics for Rare Cancers in the Genomics Era
2.
Beyond the Battle: Navigating Life After Cancer
3.
Understanding Thrombin Time: What It Is and How It Can Help Diagnose Blood Clotting Disorders
4.
Uncovering New Hope for Follicular Lymphoma Patients
5.
Beta-2 Microglobulin: Function, Role in Disease & Clinical Significance Explained
1.
International Lung Cancer Congress®
2.
Future NRG Oncology Meeting
3.
Genito-Urinary Oncology Summit 2026
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part III
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
"Lorlatinib Upfront": A Niche but Powerful Option For ALK+ NSCLC
4.
Exploring Potentials of Lorlatinib: The Third Generation ALK-TKI Through CROWN Trial
5.
The Landscape of First-Line Treatment for Urothelial Carcinoma- The Conclusion
© Copyright 2025 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation